ARTICLE | Company News
FDA approves Norditropin for adults
November 4, 2004 8:00 AM UTC
FDA approved an expanded label for Norditropin somatropin from Novo Nordisk (NVO) for use in adults with severe growth hormone deficiency. The recombinant growth hormone already is approved for use in...